chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; mild fever; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; swelling got worse; The pain got worse after the second vaccine; BP became low; This is a spontaneous report from a contactable physician. A 87-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), dose 2 via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 87-years-old) as dose 2, single for covid-19 immunisation. The patient previously received dose 1 (lot number EN6201) via an unspecified route of administration, administered in Arm Left on 10Feb2021 as dose 1, single for covid-19 immunisation and experienced pain in the right shoulder which gravitated to the elbow, forearm and hand, tha opposite side of the vaccine site. Medical history included atrial fibrillation, food allergy. The patient had no other vaccine  in four weeks. The patient was not covid prior vaccination. Concomitant medications included amiodarone; nebivolol hydrochloride (BYSTOLIC); azilsartan kamedoxomil (EDARBI). On 10Mar2021, the patient experienced the "pain got worse after the second vaccine", bp became low, Right arm became red, hot, and very painful, and on an unspecified date chills and mild fever. It was reported that the pain got worse after the second vaccine shot on 10Mar. Right arm became red, hot, and very painful (9 on 0 to 10 scale). Pain and swelling got worse the arm became totally useless, unable to make a fist or even just hold a pencil or a toothbrush. Took Tylenol to get pain relief on day 3 after the shot ibuprofen taken on day 4 after shot. Now on day 5 hand still is swollen and painful but improved enough to hold a pencil and type on keyboard. Additionally, starting on day 1 of second shot BP became low - 110/55 and remained low 120/60 even after all antihypertensive medications were discontinued. His normal BP is in the range of 140-160 systolic and 70-80 diastolic. Chills and mild fever for 6 hours happened on day 2 and for 3 hours on day 3. Temp readings not taken. Patient did not test for covid post vaccination. The patient underwent lab tests and procedures which included blood pressure diastolic: 70-80, blood pressure measurement: 120/60, blood pressure measurement: 110/55 on 10Mar202, blood pressure systolic: 140-160, pain assessment: 9 on 10Mar2021 (9 on 0 to 10 scale). Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
TC returned to patient. She questioned side effects of Flu shot. Stated that she had red streak run up arm and later up same side of neck. Stated neck felt tight. Next morning - red streak up opposite side of neck. She then informed me of "some neck surgery" in July 2010 and the she experienced problems. Problems included difficulty breathing. She stated that she was hoping that this current experience was only due to flu shot and not a blood clot. Advised her to see Dr. stated she didn't have time. Then advised her to call Dr. She stated that she would call Dr. I asked her to let me know what Dr said. She said she would do so.
Pt experienced inconsolable crying greater than 3 hours. Mom states that child began crying on the way home.  Pt came in for an office visit, vitals were stable, temp 99.6 rectally. Mom had given Motrin 2 times.
This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient. A 30-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Jan2023 at 14:30 as dose 3 (booster), single (Lot number: GJ6743) at the age of 30 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 05Jan2023 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: er8732), administration date: 21Mar2021, when the patient was 28-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: el3302), administration date: 28Feb2021, when the patient was 28-year-old, for Covid-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 05Jan2023, outcome "unknown" and all described as "flu vaccine 5Jan2023/pfizer Bivalent 5Jan2023"; PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 06Jan2023 at 08:00, outcome "not recovered" and all described as "body/joint aches"; CHILLS (non-serious) with onset 06Jan2023 at 08:00, outcome "not recovered"; PYREXIA (non-serious) with onset 06Jan2023 at 08:00, outcome "not recovered", described as "low grade fever"; VOMITING (non-serious) with onset 06Jan2023 at 08:00, outcome "not recovered", described as "multiple episodes of vomiting". Therapeutic measures were not taken as a result of vomiting, pyrexia, pain, chills, arthralgia. Additional information: The events occurred within 24 hours of booster vaccine. Other vaccine in four weeks was reported as yes. No other medications in two weeks were reported. Patient did have covid prior vaccination and did not test for covid post vaccination. No known allergies were reported. Other medical history was none.  No follow-up attempts are possible. No further information is expected.
Shortly after getting 2nd dose of Pfizer, patient felt dizzy, nauseous, and faint. She had been walking around the store and was brought by her family to sit down. She was given some Gatorade to drink and had a chair to put her feet up. Patient remained sitting for a while and left after feeling better. She regained color and strength and was able to walk out with some support from her family. Per her mom, she had not had any negative reactions on her first dose, nor has she ever had a reaction to a vaccine. Her mom also said that she had not had much to drink today. The other family members getting the vaccine were fine.
The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May-2022; Nine people vaccinated with the expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine) and PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May-2022) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Nine people vaccinated with the expired vaccine) and PRODUCT STORAGE ERROR (The vial expired on 05-May-2022, was moved to fridge on 29-Apr-2022 and was administered on 06-May-2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Patient received the booster dose on 06-May-2022..  The vial did not undergo the temperature excursion. It was reported that they have vaccinated only nine people with Moderna on 06-May-2022.  The expired vial was moved from the freezer to fridge on 29-Apr-2022   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2022: Follow received contains non-significant information-Number of patients who received expired vaccine was reconfirmed. On 11-May-2022: Follow-up received and date on which the vial moved from the freezer to the fridge was updated and event verbatim for product storage error was updated.
Myalgia, Arthralgia, NauseaVomiting, pain at injection site, fatigue Narrative:   Other Relevant History:
Patient and patient's spouse both got the first covid Moderna vaccination on 4/1. A week later on 4/8, both patient's started having rashes on both arms, feet, and behind the ears.
Hive like reaction, encompassing only the upper left arm, where injection was given. Hives abated with use of 50 mg Benadryl PO after 1 hour.
Information has been received from a Licensed Practical Nurse concerning a 16 year old female who on 30-JUN-2008 was vaccinated with the first dose of GARDASIL. On 02-SEP-2008, the patient was vaccinated with the second dose of GARDASIL. On 05-JAN-2009, at 4:20 p.m. the patient was vaccinated with the third dose of GARDASIL (lot # 661764/0650X) IM in her left arm. The patient fainted as soon as the third dose was given, and had a seizure like symptom. Blood pressure was 102/60, and the pulse was OK. Half an hour later, the patient recovered from fainted and seizure like symptom. Upon internal review, seizure like symptom was considered to be an other important medical event. No further information is available.
Information has been received from a physician concerning a 62-year-old female who on 13-JUN-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (lot# 657764/0854U).  Four weeks later, on approximately 10-JUL-2007, the patient broke out in a rash on the trunk and then it spread to her lower extremities.  Unspecified medical attention was sought.  The outcome is reported as recovered.  No product quality complaint was involved. Additional information has been requested. 12/21/07 This is in follow-up to report(s) previously submitted on 9/24/2007. Follow-up information received concerning a female with C5-6 spinal cord injury with remittent neurogenic bladder, spasticity, hypoaesthesia of trunk and extremities, osteopenia, and a history of adenoidal radiation, tubal ligation, tonsillectomy. Concomitant therapy included amitriptyline hydrochloride (MSD) 25 milligrams HS for insomia, NEURONTIN 150 (units not indicated) PRN for neuropathy and DITROPAN XL for incontinence. On 09-JUL-2007, (previously reported as approximately 10-Jul-2007) the patient developed an erythematous papular rash with questionable umbilicated vesicles. It started in her groin and developed scattered lesions on trunk and proximal extremities. It was also reported that the patient had mild irritative urinary tract symptoms, a urine culture was negative. There were no lesions in the scalp, face, palms and soles. There was no pruritus, no fever, no headaches, no myalgia and no arterial "gear". Varicella antibody titers on 30-May-2007 were positive for the varicella antibody. The rash resolved over a 2 to 3 week period. Additional information is not expected.
Patient developed shingles, diagnosed 8/8/13 and is being treated with a 7 day course of antiviral.
Received DTaP, HIB, MMR on 1/02/2002. Evening of administration large area of induration, erythema, warmth extending from hip to knee right thigh. Pt was admitted for observation.
Missed last dose of Vivotif; Spontaneous report received on 13JAN2020.  A pharmacist reported that a 64-year-old consumer "missed last dose of Vivotif" (PT: Product dose omission). The consumer was receiving Vivotif for immunisation. The consumer started Vivotif on 06JAN2020 and took three doses as per schedule but forgot to take the last dose, which was due on 12JAN2020. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer forgot to take the last dose and missed last dose of Vivotif (missed dose). The causality of missed dose is assessed as not applicable to Vivotif.; Sender's Comments: A consumer forgot to take the last dose and missed last dose of Vivotif (missed dose). The causality of missed dose is assessed as not applicable to Vivotif.
In early February, less than a month after receiving the Booster Shot at local Pharmacy, I noticed a ringing in my left ear.  This was something I never had it before. It is annoying but won't go away.  I reported to VAERS online soon after I became sure the connection  of it to the shot,  but my report was without a lot number.  I recently obtained it after some calling around including Moderna company. So this report shows the lot number for your record.
Patient was schedule for their first dose of Moderna but was administered the Janssen vaccine instead. The patient did not report any side effects.
tested positive for Covid after the first dose of the Pfizer Covid 19 Vaccine; tested positive for Covid after the first dose of the Pfizer Covid 19 Vaccine; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient tested positive for Covid after the first dose of the Pfizer Covid 19 Vaccine. The patient received remdesivir as treatment. The reporter asked if the patient can still receive the second dose of the vaccine. The outcome of the adverse events was unknown.  Information about the lot/batch number has been requested.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events drug ineffective, COVID-19 and the suspect vaccine BNT162B2.
persistent zoster-like rash from her shoulder to her elbow on the outside of her arm, neck and back which were associated with blisters and severe burning sensations; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.   In or around 18-SEP-2017, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported).    On an unknown date, reported as "shortly after receiving zoster vaccine live (ZOSTAVAX)", the pt suffered a reaction to the vaccine, causing persistent zoster-like rash from her shoulder to her elbow on the outside of her arm, neck and back which were associated with blisters and severe burning sensations. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt symptoms had resulted in physical limitations not present prior to using it. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). The event was considered as disabling events, due to the pt's permanent and incurable injuries.
Pain, swelling, tenderness and redness in my left arm; Pain, swelling, tenderness and redness in my left arm; Pain, swelling, tenderness and redness in my left arm; This is a spontaneous report from a contactable consumer (patient). A 39-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6204, Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 02Mar2021 at 11:15 (at the age of 39 years old) as second dose, single for COVID-19 immunization in a Pharmacy or Drug Store. The patient's medical history and concomitant medications were not reported. The patient has known allergies with sulfamethoxazole, trimethoprim (SEPTRA), minoxidil (BIOXCININ) and Mendel's solution on an unspecified date. The patient previously received the first dose of BNT162B2 (lot number: EL9267), via unspecified route of administration, administered in right arm on 09Feb2021 at 11:15 AM (at the age of 39 years) as first dose, single for COVID-19 immunisation. Patient was not pregnant, did not receive other vaccines in 4 weeks and no other medications in 2 weeks. On 03Mar2021 at 09:00, the patient experienced pain, swelling, tenderness and redness in my left arm. No treatment was received for the adverse event and since vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Developed chicken pox about 2 weeks after vaccination. I had contacted chicken pox previously when I was 32 years of age. Treated with Avoclyr by personal physician.
On the 9th day (Fri., 2/19) after my shot I developed a very intense rash all over my stomach, and on the underside of my breasts. It was very itchy.  I considered the possibility that it was the seafood soup I had eaten, but all day I also  had very bad pains in my lower back, left hip, and left knee. I had knee surgery in August, but this pain was much worse than I'd had in months. The pain and rash continued thru the next day Sat., 2/20.  Then on Sunday the pain was completely gone, and the rash started to subside. Then the following weekend  (2/27 and 2/28) the rash had a mild flare-up, and there's mild itching off and on since them.
Patient did not have any side effects but the  vial of Pfizer vaccine has the before use date on the bag stored in the fridge 12/12/2021 and vaccine was administered on 12/13/2021 , so Vaccine was expired for one day , by the date has been moved from freezer to the fridge.
The patient appeared pale, shaking, with a weak pulse and a BP of 90/60 approximately five minutes after the administration of the vaccines.  The patient was moved to the exam table, her legs were elevated, she was able to sip water and to respond verbally.   911 was called and the paramedics arrived quickly.  They measured her O2 level of saturation and it was 97%.  The patient was transported via ambulance to the hospital for further observation.
Extreme tiredness, body aches, headache, nausea, leg pain  It should be noted that I tested positive for COVID-19 on 1/17/21.   My symptoms were the week before:  stuffy nose, headache that last 3 days.
Swelling and redness around the injection site. Redness became hot and increased in size to the size of a grapefruit in circumference. The doctor gave me antibiotics. By three after the shot I was extremely dizzy and when I stood up I would fall over. Doctor gave me cortisone shot. Relieved some of the systems. Two weeks later I broke out with shingles in the same spot as I had over a year ago. Dr gave me medicine.
Dizziness and ringing in the ears a dew hours after the shot, flue like symptoms within 24 hours, lastly,  by 48 hours post injection a growing itchy, painful, hard red area 2.25"x2.5" at injection site
shortness of breath; difficulty breathing; low heart rate; chest pain; Light headed; DOSE 3 (BOOSTER), SINGLE; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 03Nov2021 00:30 (Lot number: 301S88A) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "DVT left leg", start date: 2006 (unspecified if ongoing), notes: Other medical history: DVT left leg 2006. No other vaccine in four weeks and no other medications in two weeks. No Covid prior vaccination. There were no concomitant medications. Past drug history included: Naproxen, reaction(s): "Known allergies", notes: Known allergies: Naproxen. Vaccination history included: first dose of Bnt162b2 (lot number= EN6204) on 17Mar2021 at 10:30 AM administered in right arm, when the patient was 65 years old, for COVID-19 immunization; and second dose of Bnt162b2 (lot number= ER8737) on 07May2021 at 11:30 AM administered in right arm, when the patient was 65 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (hospitalization) with onset 03Nov2021 00:30, outcome "unknown", described as "DOSE 3 (BOOSTER), SINGLE"; DYSPNOEA (hospitalization) with onset 03Nov2021 14:30, outcome "not recovered", described as "shortness of breath"; DYSPNOEA (hospitalization) with onset 03Nov2021 14:30, outcome "not recovered", described as "difficulty breathing"; HEART RATE DECREASED (hospitalization) with onset 03Nov2021 14:30, outcome "not recovered", described as "low heart rate"; CHEST PAIN (hospitalization) with onset 03Nov2021 14:30, outcome "not recovered", described as "chest pain"; DIZZINESS (hospitalization) with onset 03Nov2021 14:30, outcome "not recovered", described as "Light headed". The patient was hospitalized for immunisation, dyspnoea, dyspnoea, heart rate decreased, chest pain, dizziness (hospitalization duration: 2 day(s)). The events "dose 3 (booster), single", "shortness of breath", "difficulty breathing", "low heart rate", "chest pain" and "light headed" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: heart rate: (03Nov2021) low; Nasal Swab: (11Nov2021) negative, notes: covid test post vaccination. Therapeutic measures were taken as a result of immunisation, dyspnoea, dyspnoea, heart rate decreased, chest pain, dizziness included Lidocaine patch, lovanox injection, heart monitor.   Follow-up attempts are completed. No further information is expected.
1/27/21 Headache, mild fever, sore throat, diarrhea, cough. Continue as of this date.  Prescribed inhaler, steroids, and take  mucinex and tylenol.